Invivyd maintains a lean, specialized workforce numbering approximately 150 to 170 full-time employees, primarily concentrated in North America. The organizational structure is distributed across critical functional departments including research and development, clinical operations, regulatory compliance, finance, and commercial sales and marketing. This compact team structure allows the clinical-stage biopharmaceutical firm to efficiently manage its proprietary antibody discovery platforms, oversee multi-center clinical trials, and advance its commercial pipeline while controlling operational overhead.